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I. INTRODUCTION 
In the instant matter, the FTC makes frequent long leaps in logic and legal                           
analysis in an obvious attempt to force multiple arguments to surround and support this                           
case of first impression of an alleged violation of  15 U.S.C. § 45(a). The violation is the                                 
square peg of a prosecution for use of non­disparagement clauses in customer contracts in                           
the round hole of the proposition that such clauses are an unfair business practice before                             
the bill is signed into law. Conspicuously, this ex post facto allegation is buried as the                               
third count of a multiple count complaint that mostly lists paltry allegations of deceptive                           
practices. The agenda is thinly veiled and hammered violently by the Plaintiff  at the                           
expense  of  a  small  business  owner  and  provider  for  his  young  family.  
This business, family man is much, much more and it all started where Don Karl                             
Juravin was born. Mr. Juravin was born in the Holy Land of Israel where Jesus of                               
Nazareth and Moses originated and he has more in common with these religious icons                           
then just a sacred birthplace. Mr. Juravin has been regularly heralded as a worker of                             
miracles. To date, it is common place for Mr. Juravin to be showered with praise from the                                 
people whose lives he has saved by inventing, promoting and operating the gastric bypass                           
alternative.  DX  1  
The Gastric Bypass Alternative or GBA is the non­surgical method of creating the                         
same effect of bariatric surgery which is more commonly known by the more specific                           
title of, “gastric bypass,” an example of a more particular type of bariatric surgery. The                             
common thread throughout bariatric surgery, gastric bypass, the Lap Band and Mr.                       
2 
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Juravin’s GBA is simply the limitation of the capacity of the stomach. Plaintiff has                           
devoted precious resources at the taxpayers’ expense all because Defendants have the                       
gall, nerve or  chutzpah  to find a way to duplicate the effect of bariatric surgery without                               
being  gutted  by  a  scalpel  to  restructure  or  constrict  a  person’s  digestive  system. 
II. UNDISPUTED  FACTUAL  AND  PROCEDURAL  BACKGROUND 
On September 24, 2015, Plaintiff filed this action in the Middle District of Florida                           
Federal Court. (Dkt. No.1). On February 19, 2016, Plaintiff filed its Amended Complaint                         
with the Court. (Dkt. No. 48). Both the Amended and Original Complaint alleged in                           
Court Three that Defendants in this action had a contract which contained a                         
non­disparagement closure clause that was harmful to consumers.  Id.  At the time of filing                           
of the Complaint and Amended Complaint, there was no federal law prohibiting the use                           
of a non­disparagement clause in any contract. In fact, the Courts – both state and federal                               
–have supported non­disparagement clauses in contracts. There was no authority on this                       1
issue in the State of Florida.  In its Amended Complaint, Plaintiff alleges Defendants have                           
utilized “gag clauses” in agreements with their customers and threatened litigation                     
regarding violations of same. (Dkt. No. 48,  ¶¶  47­56; 67­69). In their Answer to the                             
Amended Complaint, Defendants admitted that Roca Labs requires purchasers/its                 
1  FreeLife Int’l, Inc. v. Am. Educ. Music Publications Inc. , 2009 WL 3241795 (D.Ariz. 2009);  Equal                               
Employment Opportunity Commission v. Severn Trent Services, Inc ., 358 F.3d 438 (7 TH Cir. 2004);                           
Patlovich v. Rudd, 949 F.Supp. 585, 594­95 (N.D.Ill.1996);  Eichelkraut v. Camp, 513 S.E.2d 267, 236 Ga.                               
App. 721 (Ct.App.1999);  Tenneco Inc. v. Enter. Prods. Co ., 925 S.W.2d 640, 646 (Tex.1996);  Trump v.                               
Trump , 179 A.D.2d 201, 582 N.Y.S.2d 1008 (App. Div. 1992);  Schaller v. Russak , No.                           
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customers to agree not to publicly disparage Roca Labs (Dkt. Nos. 58­64,  ¶¶ 47, 67), and                               
“filed lawsuits against customers who have breached their contracts with Roca Labs.”                       
(Dkt. Nos. 58­64,  ¶ 47). Defendants also each admitted to having the terms and                           
conditions which contain the disparagement clause accessible on their website (Dkt. Nos.                       
58­64,  ¶ 48), that “Roca Labs has required its customers to agree to not publicly                             
disparage Roca Labs” (Dkt. Nos. 58­64,  ¶¶  49­52), that the “Summary” attached to the                           
Amended Complaint as Exhibit H contains an agreement to not write any negative                         
reviews (Dkt. Nos. 58­64,  ¶ 53), and that it has taken action to enforce its contract and its                                   
legal rights, (Dkt. Nos. 58­64,  ¶¶ 54­55). With regard to the allegations in the Amended                             
Complaint pertaining to Count Three, Defendants have only denied that they have                       
“published or disclosed any protected health information” (Dkt. Nos. 58­64,  ¶ 56), and                         
the legal conclusions stated in paragraphs 68 & 69 of the Amended Complaint (Dkt. Nos.                             
58­64,  ¶¶  68­69).  
Dr. Jay Hoffman was hired by Defendants as an expert and his report pertains to                             
the issues relevant in this case, including the effectiveness of coaching in achieving                         
weight loss (DX3 ­ 97:11­25, 98:1­19), the effectiveness of the ingredients in Roca Labs’                           
Products in achieving weight loss, (DX3 ­ 100:17­25; 101; 102:1­7; 104­110), and the                         
science supporting Defendants’ claims relating to its Products and/or Regimen (DX3 ­                       
112:22­25; 113­114). Plaintiff has not challenged the validity or reliability of these                       
studies.Plaintiff has offered no evidence to contradict Dr. Hoffman’s testimony regarding                     
the efficacy of the Regimen, instead focusing solely on the ingredients in the Products                           
4 
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which, as described in the challenged claims, are merely one aspect of the Regimen. Dkt.                             
No. 48 ¶ 27a (referring to “weight loss regimen”).  The FTC’s expert, Dr. Steven                           
Heymsfield testified that the components of the Roca Labs Regimen, a 1,200 calorie a                           
day diet, plus exercise, plus a behavior modification portion, including coaching, would                       
result  in  weight  loss  with  compliant  users.  DX4  90:21­25,  91:1­3.5. 
Throughout 2014, Defendants’ Terms and Conditions stated, “your information                 
will not be shared or sold  for as long as you do not breach the Terms and we will have                                       
to use the information provided. ” Dkt. No. PX6­344 (emphasis added). The Terms and                         
Conditions explicitly and repeatedly warned potential customers that there were no                     
refunds and that Defendants may “institute legal or collection proceedings” for                     
chargebacks and for violations of its non­disparagement clause or to protect its legal                         
rights.. PX6­350­351, 353, 362, 367, 369, 370, and 383. Defendants had a detailed                         
privacy policy, including specific language regarding children’s privacy, the use of                     
cookies and pixel tags, on its website, and information that would be disclosed under                           
certain  circumstances.  Dkt.  No.  141,  PX6­367­371. 
Finally, Plaintiffs are not able to provide evidence of substantial consumer harm                       
for  any  of  its  claims. 
III.  LEGAL  STANDARD 
The Court may grant summary judgment when the movant can show there is no                           
genuine issue as to any material fact and that it is entitled to judgment as a matter of law.                                     
Fed.R.Civ.P. 56(c). Which facts are material depends on the substantive law applicable to                         
5 
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the case.  Anderson v. Liberty Lobby, Inc ., 477 U.S. 242, 248 (1986). The moving party                             
bears the burden of showing no genuine issue of material fact exists.  Celotex Corp. v.                             
Catrett , 477 U.S. 317, 323 (1986). Plaintiff has not met this burden. If the non­movant’s                             
response consists of nothing “more than a repetition of his conclusional allegations,”                       
summary judgment is not only proper, but required.  Morris v. Ross , 663 F.2d 1032, 1034                             
(11th  Cir.  1981),  cert.  denied,  456  U.S.  1010  (1982). 
Once the moving party has met its burden, the burden shifts to the nonmoving                           
party to designate specific facts showing that there is a genuine issue for trial."  Id. at 324                                 
(internal quotation marks omitted). There is a genuine issue if the combined body of                           
evidence, viewed in the light most favorable to the nonmoving party, would allow a                           
reasonable jury to find in favor of the nonmoving party.  Anderson v. Liberty Lobby, Inc. ,                             
477 U.S. 242, 248, 106 S. Ct. 2505, 91 L. Ed. 2d 202 (1986). In other words, the relevant                                     
inquiry is "whether the evidence presents a sufficient disagreement to require submission                       
to a jury or whether it is so one­sided that one party must prevail as a matter of law." Id.                                       
at 251­52. When, as here, a district court is presented cross motions for summary                           
judgment on the same issues, "[t]he court must rule on each party's motion on an                             
individual and separate basis, determining, for each side, whether a judgment may be                         
entered in accordance with the Rule 56 standard." 10A Charles Alan Wright, Arthur R.                           
Miller & Mary Kay Kane, Federal Practice and Procedure § 2720, at 335­36 (3d ed.                             
1998)  (footnote  omitted). 
IV.  CONFLICT  OF  LAW 
A. There is a conflict of laws that cannot allow for a Motion for Summary                           
6 
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Judgment  in  this  case 
1. FDA  v  FTC 
The Plaintiff knows that there is a conflict of law in the Federal system regarding                             
the regulation and advertising of supplements, but has purposefully failed to bring this                         
issue to the attention of the Court. The FDA and FTC have been in conflict for a bit of                                     
time now regarding supplements and other “alternative medicine” therapies. And no one                       
knows this better than the two agencies involved. The only ones who don’t seem to                             
realize this situation is the average business owner who believes that they are complying                           
with  the  FDA  laws,  only  to  find  out  later  that  the  FTC  is  playing  by  a  different  rulebook. 
The FDA, not Plaintiff, determines what is a supplement and what supplements                       
are able to claim. The FDA is the agency that regulates supplements, which is what the                               
Defendants here supply to the public as part of its Regimen. FDA has defined                           2
supplements as a food, and not a drug. The FDA also has given companies who                             3
distribute supplements guidelines as to what they may claim, how they may label and                           
how they may advertise. Defendants state that a supplement may state the following:                         4













Case 8:15-cv-02231-MSS-TBM   Document 167   Filed 05/09/17   Page 7 of 42 PageID 6695
a proprietary blend, just the total amount of the blend need be stated” and “Foreign                             
research could be sufficient to substantiate a claim as long as the design and                           
implementation of the foreign research are scientifically sound and the foreign research                       
pertains to the dietary supplement at issue”. Also the FDA allows for the Defendants to                             
make claims based on the  individual ingredients contained within a product, and not just                           
on the product itself. This is exactly what the Defendants in this case have done and are                                 5
able to provide. The FTC has applied a higher standard than what the FDA has stated                               
should  be  applied  to  supplements.  This  is  where  the  conflict  begins.  
The FTC admitted in an FDA hearing on homeopathic medicines that there is a                           
conflict  of  these  laws.  The  Plaintiff  states  in  its  report  to  the  FDA  the  following: 
“The FTC staff is concerned that the FDA’s existing regulatory                   
framework may conflict with the Commission’s advertising             
substantiation policy in ways that may harm consumers and  create                   
confusion  for  advertisers ”    (emphasis  added) 6
This has been a continuous aggravating issue for advertisers of natural products.                       
See National Advertising Division Case Report #4650 (04/02/07), Similisan Corp. USA,                     
Earache Relief Drops, Exhibit A. (where the company was confused about the applicable                         
standard  in  advertising  homeopathic  natural  cures).  7
At this point, the FTC also acknowledged that they are indeed stepping on the                           
5  www.fda.gov 
6 Comments of the Staff of the FTC Submitted to the FDA Dept. of Health and Human Services – In                                       
Response to a Request for Comments Related to its Public Hearing on Homeopathic Product Regulation:                             
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FDA’s proverbial shoes to enforce a broader, more strict interpretation than what the FDA                           
has informed companies who produce supplements and homeopathic remedies. This                   
conflict has caused multiple problems within the industry for business owners such as the                           
Defendants in this case. The FTC admits this in their report to the FDA. The Plaintiff                               
stated  as  follows:  
“At the very least, the potential conflict between the FDA’s                   
homeopathic CPG and the FTC’s substantiation requirement creates               
enforcement challenges for the FTC. This conflict also may create                   
uncertainty for advertisers and consumers, which may substantially               
harm  the  interests  of  both.”  8
 
Companies, such as the Defendants, find themselves caught between 2 large                     
Federal Agencies, like Odysseus between Scylla and Charybdis trying to navigate                     
troubled and uncertain advertising waters. They do this without any guidance as to which                           
Agencies  guidelines  and  rules  control  in  these  types  of  situations  until  it  is  too  late.  
When there is a conflict of Federal Agency laws, the Courts have held that, just                             
because one is broader than another, doesn’t mean they automatically win. “It is sufficient                           
for this case to observe that the Board has not been commissioned to effectuate the                             
policies of the Labor Relations Act to single­mindedly that it may wholly ignore other                           
and equally important congressional objectives.”  Southern S.S. Co. v. NLRB , 316 U.S. 31                         
at 47 (1942) (where the Supreme Court held that the NRLB overstepped its authority and                             
its chosen remedy, “trenches upon federal statute or policy outside the Board’s                       
competence to administer, the Board’s remedy may be required to yield.”  Hoffman                       
8  Id.  
9 
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Plastic  Compounds,  Inc.  v  NLRB ,  535  U.S.  137  (2002).     9
Defendants argue that there are several areas of law that conflict in this case,                           
which cannot be resolved through Summary Judgment. None of this is even mentioned,                         
or discussed in any of the pleadings put forth by the FTC. Defendants have stated on                               
multiple occasions that they believed they were following the correct law and that if they                             
had known that what they were doing was wrong, or had received a warning letter from                               
Plaintiff, they would have changed course and followed the letter of the law. Defendants,                           
in fact, changed their website multiple times to comply with varying state and local laws                             
even  though  they  are  not  business  savvy.  
Q: Do you remember talking to him [Whiting] about the possibility of                       
starting  a  business  to  market  your  invention? 
A: It didn’t start like this. I don’t remember exactly how it started. But I told him                                 
that I have ideas. I have inventions. I want to do business. But I don’t like and cannot run                                     
a business well. And I thought I’m not familiar enough with business, how to run a                               
business  in  the  U.S.  Not  even  how  to  start  a  company….  10
­­­­­­ 
Q: Why do you caveat with “for the most part”? Was somebody else involved                           
with  that? 
A: Yes. Because when you go to an FDA registered facility, you cannot bring                           
whatever you want. You can say this is what I want. But then the importer needs to                                 
coordinate with the facility to see if the facility agrees, because the facility is obligated to                               
the  FDA.  I  can  ask  anything  I  want.  But  they  can  say  no  because  whatever  reason.   11
The FTC would like this Court to believe that there is no conflict of law, while at                                 
9 See also,  Dastar Corp. v 20 th Century Fox , 539 U.S. 23 (2003), where Dastar would be in violation of                                       
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the same time admitting that there  is a conflict behind closed Agency doors. This is a                               
familiar  pattern  with  the  FTC  in  this  case  as  this  Court  will  soon  see. 
2.  Old  FTC  Law  v  New  FTC  Law 
The FTC knew when they filed this action on September 24, 2015, that there was                             
a new federal law making its way through Congress, made at the request of the Plaintiff                               
in this action. This new law was not signed until December 14, 2016 – over a year after                                   
the  filing  of  this  action.   12
What the Plaintiff has done in the instant case is purposefully hide this                         
information from the Court in an effort to get a “win” on the books and look good before                                   
Congress. To further promote this contention, they stated that this case was “settled”                         
before  Congress.    13
It seems the Agency itself cannot make up its mind as to if they need a new law to                                     
help protect citizens, or if the laws that are currently in place are sufficient. As my mother                                 
would say ­ you can’t talk out of both sides of your mouth. “Unexplained inconsistency                               14
is, at most, a reason for holding an interpretation to be an arbitrary and capricious change                               
from agency practice under the Administrative Procedure Act.”  National Cable &                     
Telecommunications Assn. v. Brand X Internet Services , 545 U.S. 967, 981, (2005).                       
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very least, this issue of contradicting laws should be considered in the least favorable                           15
light of the Plaintiff and not find in favor of summary judgment for the Plaintiff in this                                 
issue.  
3. Internal  Guideline  Conflict  at  the  FTC 
Even the internal guidelines and laws conflict within the FTC. The Plaintiff has                         
cited old guidelines from years ago regarding glasses and telemarketing, but has failed to                           
cite their own “Online Advertising Rules”. These guidelines are what the Defendant                       
would be using in this action, but these guidelines are not mentioned because this is                             
unfavorable  to  the  Plaintiff’s  position.   16
The rules are there specifically for online retailers, such as the Defendants, to help                           
them avoid FTC actions. Defendants, who have attempted to keep up with the                         17
ever­changing laws of online shops, believe that they complied with what the FTC                         
requested. The Plaintiff has stated in its own guidance literature that, “The type of                           
evidence needed to substantiate a claim may depend on the product, the claims, and what                             
experts  in  the  relevant  field  believe  is  necessary.”  18





17 The guidelines do not address non­disparagement clauses because this was addressed in state courts at                               
this time. The FTC also clearly stated in the same guidelines that “This staff guidance document only                                 
addresses disclosures required pursuant to laws that the FTC enforces. It does not address disclosures that                               
may be required pursuant to local, state ( e.g. , many sweepstake requirements), or other federal laws or                               
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they would like to follow. If this is the case, then it is clear that there is a conflict of laws                                         
that  must  be  resolved  before  this  Court  and  summary  judgment  is  not  proper.  
V.  SUBSTANTIATION  (COUNTS  I  AND  II) 
A health­related efficacy claim, which states that the product yields the                     
benefit promised, likely will mislead a reasonable consumer if the claim is                       
false or if the advertiser lacks competent and reliable scientific evidence to                       
substantiate the claim. If the FTC alleges that a claim lacks competent and                         
reliable substantiation, the defendant must produce the evidence on which                   




In NPB Adver., Inc.,  the court found the FTC expert sufficient proved the                         
inadequacy of the evidence of substantiation provided by the defendant and therefore                       
found the claims material and likely to mislead the consumer.  Id. at *10. Defendant in                             
that case sold a green tea extract product, representing that it caused substantial weight                           
loss.  Id. at *2. The evidence of substantiation he presented were studies performed on                           
green tea extract, but not his particular product.  Id. at *3. The FTC’s expert witness                             
testified in detail as to the inadequacy of the defendant’s evidence of substantiation.  Id. at                             
*8­9.  The  defendant  did  not  rebut  the  FTC’s  expert’s  testimony.  Id.  at  *10.  
In this case, Defendants’ expert, Dr. Jay Hoffman, relied on numerous published                       
scientific articles in developing his opinions. See, DX3 ­ 96:4­9, 23­25; 97; 99:18­25;                         
100; 101:11­25; 102:15­25; 104:12­25; 105; 106; 107; 108:7­13; 109:9­25; 111:21­25,                   
112; 113; 114; 115; 116. These studies are thoroughly analyzed in Dr. Hoffman’s report                           
and pertain to the issues relevant in this case, including the effectiveness of coaching in                             
13 
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achieving weight loss (DX3 ­ 97:11­25, 98:1­19), the effectiveness of the ingredients in                         
Roca Labs’ Products in achieving weight loss, (DX3 ­ 100:17­25; 101; 102:1­7;                       
104­110), and the science supporting Defendants’ claims relating to its Products and/or                       
Regimen (DX3 ­ 112:22­25; 113­114). Plaintiff has not challenged the validity or                       
reliability  of  these  studies. 
Plaintiff has offered no evidence to contradict Dr. Hoffman’s testimony regarding                     
the efficacy of the Regimen, instead focusing solely on the ingredients in the Products                           
which, as described in the challenged claims, are merely one aspect of the Regimen. Dkt.                             
No. 48 ¶ 27a (referring to “weight loss regimen”); Dkt. No. 48 ¶ 27c (“Depending on                               
your commitment to the recommended rules for suggested use, a loss of 21 lb a month is                                 
possible”); Dkt. No. 48 ¶ 27e (“Your full commitment is necessary along with a daily                             
exercise routine”). Dr. Hoffman testified that looking at the Roca Labs Products without                         
considering the Regimen was not helpful in determining the efficacy of Roca Labs,                         
stating while the dietary fibers in the Products may help users “maintain a low caloric                             
diet, . . . it's very important to take a look at Roca Labs as not the supplement by itself. It                                         
is my understanding and belief that Roca Labs sold the program. And when you look at                               
the program, that when you combine a high­fiber diet with a hypocaloric diet, you have a                               
greater chance of achieving weight loss.” DX3 ­ 77:7­20. The FTC’s expert, Dr. Steven                           
Heymsfield testified that the components of the Roca Labs Regimen, a 1,200 calorie a                           
day diet, plus exercise, plus a behavior modification portion, including coaching, would                       
result  in  weight  loss  with  compliant  users.  DX4  90:21­25,  91:1­3.5. 
14 
Case 8:15-cv-02231-MSS-TBM   Document 167   Filed 05/09/17   Page 14 of 42 PageID 6702
VI.  HEALTH  CLAIMS  (COUNTS  IV  AND  V) 
A. Plaintiff cannot claim that there is no material issue of fact regarding the                         
scientific  claims  made  by  Defendants 
Plaintiff in this case has taken several liberties when describing Defendants’                     
Regimen in an effort to distract from the truth of the matter that FTC overreach is                               
becoming  commonplace,  even  when  in  conflict  with  other  Federal  Agencies.  
First, Plaintiff have mischaracterized Defendants’ product. Defendants have               
always sold and promoted the  entire Regimen – which includes drinking three liters of                           19
water, 30 minutes of exercise and eating less overall. Since its inception, the Regimen has                             
included these things not only for the effect, but also for the health and safety of                               
Defendants customers. What is also very ironic is that this is also the very same advice                               
given to those who also participate in bariatric surgery, for the exact same reason ­ health                               
and  safety.   20








see also  https://medlineplus.gov/ency/patientinstructions/000173.htm , citing Mechanick JI, Kushner RF,               
Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and                         
American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the                           
perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient.  Obesity (Silver                         
Spring) . 2009;17 Suppl 1:S1­70. PMID: 19319140  www.ncbi.nlm.nih.gov/pubmed/19319140 , Heber D,                 
Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post­bariatric surgery                           
patient: an Endocrine Society Clinical Practice Guideline.  J Clin Endocrinol Metab .                     
2010;95(11):4823­4843. PMID: 21051578  www.ncbi.nlm.nih.gov/pubmed/21051578 , Thompson CC,           
Morton JM. Surgical and endoscopic treatment of obesity. In: Feldman M, Friedman LS, Brandt LJ, eds.                               
Sleisenger & Fordtran's Gastrointestinal and Liver Disease . 10th ed. Philadelphia, PA: Elsevier Saunders;                         
2016:chap  8.  
15 
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● Avoid  carbonated  drinks” 
Defendants also clearly state that they are not promotion a surgery of any kind,                           
nor are they promoting any sort of medical procedure or advice. Defendants state                         
repeatedly that they are offering a natural alternative to those options instead, in the                             21
hopes of saving customers thousands of dollars in an irreversible surgery. Even if the                           
person finds that they cannot keep to the Regimen, they will at the very least think twice                                 
before jumping recklessly into a possibly dangerous surgery at a time when most media                           
outlets  continuously  downplay  its  serious  nature.   22
In addition, the “effect” of Defendants’ product is true to form. The description of                           
the Regimen and what it does is exactly what it is supposed to do – which is reduce the                                     
capacity available in the stomach for food. Plaintiffs in this case want facts set by an                               
arbitrary standard which any company that is not backed by a large pharmaceutical would                           
be hard pressed to do. The courts have stated, “we agree with appellants that the APA                               
requires the agency to explain why it rejects their proposed health claims—to do so                           
adequately necessarily implies giving some definitional content to the phrase "significant                     
scientific agreement." We think this proposition is squarely rooted in the prohibition                       
under the APA that an agency not engage in arbitrary and capricious action.  See 5 U.S.C.                               
§ 706(2)(A) (1994). It simply will not do for a government agency to declare—without                           
explanation—that a proposed course of private action is not approved.  See Motor Vehicle                         
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L.Ed.2d 443 (1983) ("[T]he agency must . . . articulate a satisfactory explanation for its                             
action. . . ."). To refuse to define the criteria it is applying is equivalent to simply saying                                   
no  without  explanation.”  Pearson  v  Shalala ,  164  F.3d  650  (1999).  
Defendants have provided studies and can prove that the Regimen, as a whole                         
can, cause weight loss similar to the claims made on the website. Even the Plaintiffs own                               
experts stated it was possible. Dr. Steven Heymsfield stated in his February 24, 2017                           
deposition  the  following: 
Q: So, in light of that [describing the entire Regimen in the                       
prior answer], would you agree that those components of the                   
Roca Labs regimen, a 1200 calorie a day diet, plus exercise,                     
plus behavior modification portion, including coaching, would             
be likely or would absolutely result in weight loss with                   
compliant  users? 
A: The – the answer is yes, but is says nothing about whether or                           
not  the  Roca  Labs  product  contributes  to  that  weight  loss.   23
Dr.  Hoffman  also  supported  the  claims  of  the  Defendant 
Q: All right It’s the FTC’s position, as we stated in our                       
complaint, that Roca Labs is claiming that use of its product,                     
including the Roca Labs Formula and Anti­Cravings, enables               
consumers to reduce food intake by 50 percent and lose                   
substantial amounts of weight quickly, including as much as 21                   
pounds in one month and as much s 100 pounds in seven to ten                           
months. Are you offering an expert opinion that there is a                     
competent and reliable scientific evidence to substantiate that               
claim? 
A: I believe there’s scientific evidence to support that those – that                       
possibility of a subject at a certain body mass within the 95 percent                         
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amount  of  weight.  That  is  very  credible.  
And  on  Page  13  of  DX3 
Q: You said in the Walsh study, on 31, paragraph 31, the last                         
sentence, “this study appeared to be one of the first to indicate                       
the efficacy of glucomannan.” You’re not using the word                 
indicate”  to  mean  prove  the  efficacy  of,  are  you? 
A; They’re the first study to publish that glucomannan had a                     
positive  effect  on  weight  loss.  
Q: When you say “indicate”, do you mean establish, prove                   
efficacy,  or  do  you  mean  indicate? 
A: Suggest. Generally, in science you want to speak – indicate                     
what had – what occurred. Their results indicate. IT doesn’t make                     
it validated, it indicated. The results indicated that glucomannan                 
caused a significant increase in weight loss. It wasn’t suggested,                   
they  actually  showed  a  significant  increase.  So,  it  was  indicated.    24
 
Even these scientists cannot disclaim the effect of the entire Regimen. Even                       
though the Plaintiff continued to question study after study with Dr. Hoffman, the study                           
results did not magically change, and therefore neither could his answers. Defendants                       25
have cited repeatedly to study after study, and can provide each one to the Court for                               
review, on the ingredients within the Formula, as well as intermittent fasting, reduced                         
caloric intake, the effect of the increase of fiber in the diet – all which are a part of the                                       
Defendant’s Regimen. This is what the Plaintiff does not want to discuss. Because by                           
admitting, even in small part, that Defendants’ claims may be true and supported by real                             
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was  “settled’.  And  no  one  likes  to  look  bad  in  front  of  the  boss.  
The side effect of the Regimen is the weight loss, not the actual product itself.                             
And the Regimen really works. Sharon King, who was deposed by the Plaintiff in this                             
case  provided  multiple  stories  from  people  who  actually  lost  weight  on  the  Regimen   26
A: Sometimes, you know, I would – the one woman that was a                         
nun,  Sister… 
Q:  Sister  Ann? 
A: Sister Ann. She approached me – she didn’t lose the weight, she                         
asked if she could have the product for free because she didn’t                       
have the money. You know, you take a vow of poverty. She wanted                         
– she said: I don’t care if its expired I just need help. I’m a school                               
teacher, I can’t keep up the my kids. So, I offered to send her                           
product  for  free,  you  know,  to  help  her  out.  So,  that’s  just  one. 
And the one that you don’t – that her face I covered she lost 90                             
pounds. So, these people were real people that really lost the                     





A: Yeah. I had one man that lost 200 pounds and went skydiving. I                           
mean A lot of people are so private about their weight loss they                         
don’t want people to know. He showed me this video, said: Don’t                       
tell anybody. I don’t want to be a coach. I don’t want you to show                             
my pictured to your boss or anything its just between me and you                         
Sharon. You know, I didn’t even tell Don. You know, it was just                         
like  I  had  the  communication  with  him,  so  you  know.  
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A: It was more than a couple a month. I would say, you know,                           
maybe  about  20  a  month.  I  would  say  about  20  a  month.  
By misconstruing the claims of the Defendants and creating a moving target for                         
the Defendants to hit, the Plaintiffs have rigged the game in their favor. Like a carnival                               
game with very high stakes, the Defendants have to continually attempt to reach an even                             
higher bar than what was set before to make the Plaintiff happy. It does not matter that                                 
there are scientific studies on the ingredients, there now must be scientific studies on the                             
Formula, It doesn’t matter that there is a study on the Formula, now it must be a study                                   
that lasts over a year. It doesn’t matter that there are studies on animals on the efficacy of                                   
the individual ingredients, there must be multiple studies on humans – and of the same                             
weight  and  sex  and  height  and  eye  color  as  what  the  Defendants  claim.  
There is a material issue of fact in this case. Defendants, their experts, the                           
Plaintiff’s expert and the studies that are the true subject of this debate bring into question                               





The FTC has attempted to, “pile on,” with an additional and thin argument                         
regarding an allegation of a deceptive pricing structure. There is no sin committed by the                             
Defendants in this allegation by their tireless efforts to promote the Roca Labs’ Gastric                           
Bypass Alternative as any business would attempt in proper marketing of their product in                           
20 
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the highly competitive area of online commerce. Plaintiff correctly states Defendants                     
regularly offered the Roca Labs package for the total price of $480 with certain                           
conditions. (Dkt. No. 141 at page 11) Plaintiff also provides numerous references to the                           
record regarding search advertisements, display advertisements served through Google                 
and Bing, and advertisements on Facebook. (Dkt. No. 141 at pages 11­12) In order to set                               
up the invalid argument of deceptive pricing, Plaintiff attempts to vilify Defendants’                       
reasonable  marketing  campaign  with  the  pervasive  nature  of  their  online  advertisements. 
The FTC continues this transparent assertion with the dramatic revelation that                     
there was a mysterious and secret pricepoint hidden on the website which could not                           
possibly be unearthed. The following step in Plaintiff’s attempts to smear the Defendants’                         
mission to save the lives of obese persons, is to provide a negative discussion about the                               
clickwrap  (emphasis added) feature of the website designed to efficiently allow                     
customers to affirmatively agree and accept the purchase qualifications and terms of the                         
transaction. Plaintiff correctly states that the website includes at the bottom of the                         
purchase selection screen and above the, “Submit,” button was an unchecked box next to                           
the statement, “I have checked and do not have any medical reason that can prevent me                               
from using the Gastric Bypass Alternative procedure and I have read and agree to the                             
terms, privacy and money back reward / return policy.” (Dkt. No. 141 at 12) Additionally,                             
it is true that customers were not required to read the, “Terms and Conditions” which are                               
fully available by a hyperlink at the bottom of each webpage. Plaintiff’s Exhibit to                           
Complaint (Dkt. 2, Part II, pages 12,16,22,25,32, 36,46, 48, 56; Part I, pages 3,10, 12, 16,                               
21 
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22, 26, 29, 34, 37, 47) Defendants did not hide the, “set price,” of $1580 or the terms for                                     
which the subsidized price of $480 could be achieved. Plaintiff’s Exhibit to Motion for                           
Summary Judgment (Dkt. No. 141­7, pages 319 ­ 320) On the contrary, access to the                             
terms and conditions were consistently and prodigiously provided by hyperlink                   
throughout  the  online  site.  
The FTC dramatically brings this tale to a conclusion with an untruthful                       
contention that the customer’s first opportunity to know the set price of $1580 and                           
conditions to qualify for the subsidized price point is in the printed, “Terms and                           
Conditions,” included in the packaging of the delivered product. (Dkt. No. 141 at page                           
12) Plaintiff’s fatally flawed argument completely depends on the assumption that the                       
customer did not click on the hyperlink provided on the website and did read the printed                               
materials in the shipment. Both opportunities to learn of the, “Terms and Conditions,” are                           
equally  accessible  and  fare  the  same  chance  of  being  ignored  by  the  customer.   
Additionally, Plaintiff’s bewildering argument teeters upon the precipice of the                     
legality of clickwrap agreements. Courts have previously decided multiple cases on                     
clauses contained within a “clickwrap” contract online. “Clickwrap” has been defined by                       
the courts as an “agreement (that) appears on an internet webpage and requires that a user                               
consent to any terms or conditions by clicking on a dialog box on the screen in order to                                   
proceed with the internet transaction.”  Specht v. Netscape Comms. Corp ., 306 F.3d 17, 22                           
(2d Cir. 2002). In addition, courts have also found that such agreements are enforceable                           
by applying the traditional principles of contract law. See,  Specht , 306 F.3d at 28­30;                           
22 
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Forrest v. Verizon Communications, Inc., 805 A.2d 1007, 1010 (D.C. Cir. 2002);  Barnett                         
v. Network Solutions, Inc. , 38 S.W.3d 200 (Tex. App. 2001);  Caspi v. Microsoft Network,                           
L.L.C., 323 N.J. Super. 118, 125­26 (App. Div. 1999); John M. Norwood, “A Summary                           
of Statutory and Case Law Associated with Contracting in the Electronic Universe,” 4                         
DePaul Bus. & Comm. L.J. 415, 439­49 (2006) (discussing clickwrap cases); 1­2                       
Computer Contracts §2.07 (2006) (analyzing clickwrap cases). Also, the Courts have                     
found that failure to read an enforceable clickwrap agreement  will not excuse compliance                         
with its terms. See,  Specht , 306 F.3d at 30;  Lazovick v. Sun Life Ins. Co. of Am ., 586 F.                                     
Supp.918, 922 (E.D. Pa. 1984);  Barnett , 38 S.W.3d at 204;  Siedle v. Nat'l Assoc. of Sec.                               
Dealers, Inc. , 248 F. Supp. 2d 1140, 1143 (M.D. Fla. 2002);  Management Computer                         
Controls, Inc. v. Charles Perry Constr., Inc. , 743 So.2d 627 (Fla. 1st DCA 1999)                           
Defendants mention multiple times on their website that the consumer is required to read                           
the “terms and conditions” prior to purchase. Plaintiff’s Complaint Exhibits (Dkt. 2, Part                         
II, pages 11,12,16, 22, 32,34, 35, 36, 46, 47, 48 and 56.) Defendants’ actions are in clear                                 
compliance of contract law as stated in  Feldman v. Google, Inc ., 513 F. Supp. 2d 229,                               
Dist. Court, ED Pennsylvania 2007, citing  Forrest v. Verizon Communications, Inc.,  805                       
A.2d 1007, 1010­11 (D.C. Cir. 2002) (holding that adequate notice was provided of                         
clickwrap agreement terms where users had to click “Accept” to agree to the terms in                             
order to subscribe),  Caspi v. Microsoft Network, L.L.C., 323 N.J. Super. 118, 122, 125­27                           
(App. Div.1999)(finding that reasonable notice of the terms of a clickwrap agreement was                         
provided where the user had to click “I agree” before proceeding with registration.). The                           
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record substantiates Defendants’ clear intention to establish a valid agreement and                     
sufficiently notice the customer of the set price of $1580 as well as the conditions to                               
receive  the  subsidized  price  of  $480.  
The FTC draws this empty accusation out by a string of baseless arguments that                           
stack like a house of cards. First, Plaintiff points out Defendants’ pervasive attempts to                           
market online a business that saves lives in a manner that suggests deception about a                             
price point that was used regularly in sales. Second, Plaintiff denigrates the lawful and                           
widely utilized mechanism of the clickwrap agreement by unconscionably characterizing                   
the programmed feature as inherently deceptive. Thirdly, Plaintiff untruthfully state that                     
the set price is not revealed to the consumer until after delivery of the shipment is                               
received and opened. Despite Plaintiff’s attempt to manufacture a deceptive price point                       




Plaintiff claims Defendants’ endorsements were deceptive and therefore violated                 
Section 5(a) of the FTC Act, 15 U.S.C. § 45(a). Dkt. No. 141 pp. 8­9, 21, 32. The facts                                     
cited by Plaintiff as evidence for this deception were Defendants’ information about                       
bariatric surgery and “alternatives to surgery”, use of testimonials, and omissions of                       
disclosure on GastricBypass.me site. Dkt. No. 141 pp. 8­9. Plaintiff claims Defendants                       
violated section 5(a) of the FTC Act, 15 U.S.C. § 45(a) when they ran an “informational”                               
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website educating consumers about gastric bypass surgery while promoting Roca Labs                     
products,  and  using  testimonials.  Dkt.  No.  141  pp.  21,  33. 
Defendants were dedicated to educating people about negative effects of bariatric                     
surgery and “alternatives to surgery”. Defendants admit GastricBypass.me did not state it                       
was affiliated with RLI. There is a dispute of fact as to whether some of the “satisfied                                 
consumers” in the videos were paid “independent contractors.” Roxie initially became                     
acquainted with Roca Labs as a customer, as evidenced in her deposition stating as                           
follows:  







A. I was researching gastric bypass on the Internet, and it popped up                         











A. After the first three months, I was ­­ I ran out of my formula, probably four                                 
months, and I called in to do a reorder. I then received an e­mail from Sharon King                                 
wanting to know about my success, how I was doing, and how much weight I had                               
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lost. And then she asked if I would be interested in becoming a success coach in                               
2013,  around  April. 
 
Dkt. 141, PX12­7(30:9­18), pg. 8(32:17­25); (33:1­3), pg. 8­9. While her video was                       
recorded subsequent to her employment, the account of her success related to results                         
acquired  prior  to  becoming  an  employee  of  the  Defendants. 
  Plaintiff claims Defendants ran a fake “informational” website, purporting to                   
educate consumer while promoting Roca Labs products is vague, violates due process,                       
and fails to explain how such conduct violates the law. Information found on Defendants’                           
site aided to informing customers regarding potentially serious, life­changing, body                   
altering  decisions,  such  as  gastric  bypass  surgery. 
Further, even if the Court finds the endorsements were deceptive, Plaintiff has                       
offered no evidence showing the endorsements have caused or will likely cause                       
substantial injury to consumers as required by the FTC Act, nor can it. Additionally,                           
Plaintiff cannot show any harm came as a result of Defendants sharing information about                           
bariatric surgery while promoting Roca Labs products. Nor can Plaintiff show that any                         
harm came as a results of Defendants use of their endorsements. Furthermore, it does not                             
even  try  to  allege  any  harm  was  caused  as  a  result  of  the  endorsements. 
Based on the foregoing, Plaintiff has not met its burden to show there are no                             
issues of material fact relating to Defendants’ endorsements and its alleged                     
misrepresentation of same and its Motion for Summary Judgment with respect to Counts                         
IV  and  V  should  be  DENIED. 
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VIII.  PRIVACY  POLICY  (COUNT  VI) 
Plaintiff claims Defendants’ privacy promises were deceptive and therefore                 
violated Section 5(a) of the FTC Act, 15 U.S.C. § 45(a). Dkt. No. 141 pp. 9­11, 21­22,                                 
33. The facts cited by Plaintiff as evidence for this deception were Defendants’ use of                             
information provided by customers in a pre­purchase qualification form completed by                     
potential Regimen users. Dkt. No. 141 pp. 10­11. Plaintiff claims Defendants violated                       
section 5(a) of the FTC Act, 15 U.S.C. § 45(a) when they used certain information in the                                 
forms of four customers in litigation and other customers in defending credit card                         
disputes  with  credit  card  companies.  Dkt.  No.  141  pp.  21­22,  33. 
Defendants admit certain information about certain customers that was found in                     
the qualification form was included in complaints filed in Florida state court against four                           
customers and in communications with credit card companies in order to defend against                         
payment disputes made by certain customers. There is no evidence in the record that                           
Defendants disclosed information that was not otherwise publicly available, nor is there                       
evidence that Defendants disclosed information about customers other than as required to                       
protect their own legal rights in litigation and/or disputes with credit card companies that                           
were initiated by customers. There is no evidence that Defendants sold private health                         
information to third party vendors nor that it publicly disseminated any information other                         
than in court documents. In fact, Plaintiff is not even accusing Defendants of engaging in                             
such  activities.  Dkt.  No.  140,  pp.  9­11,  21­22,  33.  
Further, even if the Court finds the privacy promise was deceptive, Plaintiff has                         
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offered no evidence showing the privacy promise has caused or will likely cause                         
substantial injury to consumers as required by the FTC Act, nor can it. “In the early                               
2000s, the FTC de­emphasized its fair information practices approach as the primary                       
means of addressing privacy issues, and shifted its focus to a “harm­based approach” for                           
protecting consumer privacy. The approach was designed to target harmful uses of                       
information – those presenting risks to physical security or economic injury, or causing                         
unwarranted intrusions in our daily lives – rather than imposing costly notice and choice                           
for all uses of information. The Commission’s privacy agenda began to focus primarily                         
on: (1) data security enforcement; (2) identity theft; (3) children’s privacy; and (4)                         
protecting consumers from spam, spyware, and telemarketing.” Prepared Statement of the                     
Federal Trade Commission on Consumer Privacy Before the Committee on Commerce,                     
Science,  and  Transportation,  United  States  Senate,  Washington,  D.C.,  July  27,  2010,  p.  5.  
Until this case, the FTC has been focused on privacy as it relates to data security                               
breaches, identity theft, children’s privacy, and “unwanted intrusions” (spam,                 
telemarketing calls, etc.). Id. at pp.6­13.  It appears Defendants are the first and only                           27
27  The FTC has taken action against companies for failing to disclose they were selling/sharing consumer’s                               
information to third parties (see e.g., In the Matter of Geocities, FTC Docket No. C­3850, 1999; In the                                   
Matter of Facebook, Inc., FTC Docket No. C­4365, 2012), misrepresenting the anonymity of financial                           
information collected from minors (see e.g., In the Matter of Liberty Financial Companies, Inc., FTC                             
Docket No. C­3891, 1999), misrepresenting the level of online security and encryption used to protect                             
consumers’ private information (see e.g., FTC v. Rennert, Sandra L., et al., (D. Nev. Case No.                               
00­cv­0861­JBR), using information collected from millions high school students to market services to                         
those students (see e.g., In the Matter of The National Research Center For College and University                               
Admissions, Inc., and Don M. Munce, FTC Docket No, C­4071, 2003), participating in identity theft scams                               
(FTC v. Hill, SD Texas Case No. 03­cv­5337), placing tracking software on consumers’ computers without                             
disclosing same, (In the Matter of Sears Holdings Management Corporation, a corporation, FTC Docket                           
No. 4264, 2009) not taking appropriate steps to protect consumers’ private information (see e.g., In the                               
Matter of CVS Caremark Corporation, a corporation, FTC Docket No., C­4259, 2009; In the Matter of                               
Google, Inc., FTC Docket No., C­4336, 2011), collecting information from consumers without disclosing                         
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entities against which Plaintiff has ever pursued a privacy policy violation in which the                           
only instances in which the consumer information was shared was in a court pleading or                             
in defense of customer credit card chargebacks.  It is well­established that “an agency                         
literally has no power to act . . . unless and until Congress confers power upon it.”  La.                                   
Pub. Serv. Comm’n v. F.C.C. , 476 U.S. 355, 374 (1986). Moreover, “a fundamental                         
principle in our legal system is that laws which regulate persons or entities must give fair                               
notice of conduct that is forbidden or required.”  F.C.C. v. Fox Television Stations, Inc. ,                           
132  S.  Ct.  2307,  2317  (2012). 
The customer questionnaire cited by Plaintiff in its Motion stated, “[t]his                     
information will be kept confidential and will NOT be shared,” immediately after which                         
Defendants placed a link to their privacy policy. Dkt. 141­10, PX6­829. Don Juravin                         
testified that this was in place at some point in 2014. (DX6, 154:14­155:25.) Throughout                           
2014, Defendants’ Terms and Conditions stated, “your information will not be shared or                         
sold  for as long as you do not breach the Terms and we will have to use the information                                     
provided. ” Dkt. No. 141­PX6­344 (emphasis added). The Terms and Conditions                   
explicitly and repeatedly warned potential customers that there were no refunds and that                         
Defendants may “institute legal or collection proceedings” for chargebacks and for                     
violations of its non­disparagement clause or to protect its legal rights.. PX6­350­351,                       
353, 362, 367, 369, 370, and 383. Moreover, Defendants had a much more detailed                           
said information was being collected (see e.g., FTC v. Vizio, Inc. et al., Dist. NJ Case No. 17­cv­00758),                                   
publicly posting personal health information on the Internet without consent (In the Matter of Practice                             
Fusion, Inc., FTC Docket No. C­4591, 2016), and publicly posting nude photos on the Internet without the                                 
subject’s  consent  (In  the  Matter  of  Craig  Brittain,  C­4564,  2016). 
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privacy policy than Plaintiff would have the Court believe, including specific language                       
regarding children’s privacy, the use of cookies and pixel tags, on its website, and                           
information that would be disclosed under certain circumstances. Dkt. No. 141,                     
PX6­367­371.  
Additionally, Plaintiff cannot show any harm came as a result of Defendants                       
sharing information necessary to protect its legal rights. It does not even try to allege any                               
harm was caused beyond the mere disclosure of the information in court documents and                           
to  credit  card  companies. 
Based on the foregoing, Plaintiff has not met its burden to show there are no                             
issues of material fact relating to Defendants’ privacy policy and its alleged                       
misrepresentation of same and its Motion for Summary Judgment with respect to Count                         
VI  should  be  DENIED. 
VII.  NON­DISPARAGEMENT  CLAUSE  (Count  III) 
Defendants filed a Motion for Partial Summary Judgment relating to Count III                       
(Dkt. No. 143). Defendants will not rehash all their arguments contained in their motion                           
in  this  Response,  but  do  incorporate  that  motion  herein.  
A. Plaintiff has not shown Defendants violated 15 U.S.C. § 45(a) – unfair                       
practices 
 
Plaintiff argues Defendants engaged in “unfair practices” by having a                   
non­disparagement clause in their agreement with customers and by enforcing that                     
agreement when it was breached. In addition to Defendants’ arguments stated in their                         
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Motion for Partial Summary Judgment that they have not violated 15 U.S.C. § 45(a)                           
because only the recently signed Consumer Review Fairness Act of 2016 actually applies                         
to the non­disparagement clause in the contract, Plaintiff has not met its summary                         
judgment  burden  as  to  the  elements  of  an  unfair  practice. 
Section 5(n), sets forth the test for “unfair” practices. In it, Congress explicitly                         
provided the Commission “ shall have no authority ” to declare an act or practice “unfair”                           
“unless the act or practice [1] causes or is likely to cause substantial injury to                             
consumers[,] [2] which is not reasonably avoidable by consumers themselves[,] and [3]                       
not outweighed by countervailing benefits to consumers or to competition.” 15 U.S.C. §                         
45(n) (emphasis added). Plaintiff seeks to have the Court eviscerate several of these                         
critical  limits. 
1. Plaintiff  provides  no  evidence  of  tangible  consumer  harm 
In regard to Section 5(n)’s first prong, there is no evidence that the                         
non­disparagement clause, and the enforcement of same, caused any tangible consumer                     
harm (meaning economic or physical injury). To address this evidentiary gap, Plaintiff                       
argues that the intangible harm of unknown and unnamed potential consumers not being                         
able to view all negative reviews, truthful or not, is “substantial injury” under Section                           
5(n). (Dkt. No. 141, pp.35­37). This is clearly not the type of injury contemplated by                             
Section  5(n). 
First, the FTC’s interpretation of “substantial injury” contravenes the term’s plain                     
meaning. The plain meaning of “substantial injury,” as used by Congress when it enacted                           
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Section 5(n) in 1994, must be derived from the FTC’s then­operative definition of                         
“substantial injury” as set forth in the FTC’s prior policy statements to Congress on this                             
very question. See  United States v. Myers , 972 F.2d 1566, 1572 (11th Cir. 1992)                           
(“Congress is deemed to know the executive and judicial gloss given to certain language                           
and thus adopts the existing interpretation unless it affirmatively acts to change the                         
meaning.”). And the FTC’s pre­enactment policy statements are crystal clear that, as of                         
the enactment of Section 5(n), the FTC defined “substantial injury” to require “tangible                         
injury.” 
Specifically, the FTC’s 1980 Policy Statement on Unfairness (the “Policy                   
Statement”), Letter from FTC to Senators Ford and Danforth (Dec. 17, 1980), appended                         
to  In re Int’l Harvester Co., 104 F.T.C. 949, 1984 WL 565290, at *95 (1984), expressly                               
stated in its discussion of the meaning of the term “substantial injury” that “[e]motional                           
impact and other more subjective types of harm . . . will not ordinarily make a practice                                 
unfair,” Policy Statement, 1984 WL 565290, at *97, *104 n.16. Similarly, the FTC’s                         
1982 policy letter clearly stated that, “as a general proposition substantial injury “does                         
not cover subjective examples of harm.” Letter from FTC Chairman J.C. Miller, III to                           
Senators Packwood and Kasten (March 5, 1982) (“Policy Letter”), reprinted in H.R. Rep.                         
No. 156, pt. 1, 98th Cong., 1st Sess. 27, 32 (1983) (hereinafter cited by reference to H.R.                                 
Rep. No. 156). Commissioner Olhausen testified in 2012, that in the Policy Statement,                         
the Commission “specifically advised Congress that absent deception, it will not enforce                       
Section 5 against alleged intangible harm.” Stmt. of Commissioner Maureen K.                     
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Ohlhausen to Senate Committee on Commerce, Science & Transportation, 2012 WL                     
1612706  (May  9,  2012).  
Second, if the statute’s plain meaning were not dispositive, the FTC’s                     
interpretation of “substantial injury” as including intangible injury is directly at odds with                         
Section 5(n)’s legislative history, which states in no uncertain terms that intangible                       
injuries are not cognizable as “substantial injury” under Section 5(n). See, e.g., S. Rep.                           
103­130, 1993 WL 322671, at *13 (1993) (“Emotional impact and more subjective types                         
of harm alone are not intended to make an injury unfair.”). Subsequent legislative                         
enactments also make clear that “substantial injury” does not include intangible injury.                       
See  F.T.C. v. Wyndham Worldwide Corp. , 799 F.3d 236, 248 (3d Cir. 2015) (noting that                             
the Gramm­Leach­Bliley Act, which the FTC enforces, “relieves some of the                     
burdensome [Section 5(n)] requirements for declaring acts unfair” because it permits the                       
FTC to establish standards protecting not only against “substantial harm,” but also                       
against  “inconvenience”  to  consumers). 
Even if intangible harm could be “substantial injury” under Section 5(n),                     
moreover, there is no evidence that Defendants caused any such harm here. Plaintiff                         
provides the Court with no basis upon which to find that any consumer or potential                             
consumer actually suffered any such intangible harm as a result of the alleged chilling                           
effect of the disparagement clause. (DX7 ­ 111:22­112:12.) In fact, there is ample                         
evidence that the disparagement clause did not work, and as a result, there were, and still                               
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are, negative reviews posted online by Defendants’ customers. Accordingly, even if                     28
intangible harm could qualify as substantial injury, which it cannot, Plaintiff’s assertion                       
that  Defendants’  non­disparagement  clause  caused  substantial  injury  would  still  fail.  
2. Plaintiff Failed to Accurately Conduct the Cost­Benefit Analysis Required by                   
Section  5(n)’s  “Countervailing  Benefits”  Prong 
By barring the FTC from declaring a practice “unfair” where any substantial                       
consumer injury caused or likely to be caused by the practice is “outweighed by                           
countervailing benefits to consumers or to competition,” Section 5(n)’s“countervailing                 
benefits” prong “informs parties that the relevant inquiry [under that prong] is a                         
cost­benefit analysis . . . that considers a number of relevant factors, including the                           
probability and expected size of reasonably unavoidable harms to consumers given a                       
certain level of cybersecurity and the costs to consumers that would arise from                         
investment in stronger cybersecurity.”  Wyndham, 799 F.3d at 255. In applying this prong,                         
the FTC must also “take into account costs related to a prospective remedy, including but                             
not limited to direct costs to the parties.” Policy Letter at 32; see Policy Statement, 1984                               
WL  565290,  at  *97. 
In this case, Section 5(n) requires the Court to compare (1) the sum of (a) the                               
costs to Defendants of false negative reviews and (b) the additional costs associated with                           
Defendants’ compliance with any order forbidding the disparagement clause going                   
forward (collectively, the “Relevant Costs”), with (2) the magnitude of any substantial                       
28 Hence, Plaintiff’s argument that not seeing negative reviews of the Regimen is “not reasonably                             
avoidable  by  consumers”  also  fails. 
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consumer injury caused or likely to be caused by the disparagement clause and the                           
attempts to enforce same (the “Relevant Benefits”). Plaintiff has made no attempt to                         





Even if the FTC’s interpretations of its Section 5 authority are otherwise sound,                         
the Commission could not apply them to Defendants because between 2010 to                       
September 2015—the only relevant time period in this case—Defendants did not have                       
fair notice the FTC would adopt these interpretations in this case. “A fundamental                         
principle in our legal system is that laws which regulate persons or entities must give fair                               
notice of conduct that is forbidden or required.”  F.C.C. v. Fox Television Stations, Inc. ,                           
132 S. Ct. 2307, 2317 (2012). The fair notice doctrine “prevents . . . deference from                               
validating the application of a regulation that fails to give fair warning of the conduct it                               
prohibits or requires.”  Gates & Fox Co., Inc . v. O.S.H.R.C., 790 F.2d 154, 156 (D.C. Cir.                               
1986).  
Moreover, where a court defers to an agency interpretation of its governing statute                         
or its own regulation, and based on that interpretation the agency proposes to hold a party                               
liable, the Due Process Clause requires that the agency’s interpretation must have been                         
knowable with “ascertainable certainty” at the time the party committed the alleged                       
violation. See  Ga. Pac. Corp. v. O.S.H.R.C. , 25 F.3d 999, 1005–06 (11th Cir. 1994). This                             
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means that, “by reviewing the regulations and other public statements issued by the                         
agency, a regulated party acting in good faith would be able to identify, with                           
‘ascertainable certainty,’ the standards with which the agency expects parties to                     
conform.”  Howmet  Corp.  v.  E.P.A .,  614  F.3d  544,  553–54  (D.C.  Cir.  2010). 
Prior to the beginning of the Relevant Period in 2010 the FTC had never provided                             
Defendants with any ability to know with “ascertainable certainty” of the FTC’s                       
interpretation that intangible and even purported conceptual consumer injuries can                   
constitute “substantial injury.” See  Ga. Pac. , 25 F.3d at 1005–06;  Gen. Elec. Co. v.                           
E.P.A ., 53 F.3d 1324, 1330 (D.C. Cir. 1995);  PMD Produce Brokerage Corp. v. U.S.D.A. ,                           










Plaintiff has stated within its pleadings that disgorgement is the correct remedy                       
for the alleged violations of the FTC Act by the collective Defendants. Defendants argue                           
that  this  is  incorrect.  
Defendants state Plaintiff has failed to provide this Court with even the most basic                           
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of elements to support disgorgement. Plaintiff must provide the Court with at least some                           
calculation for disgorgement to be proper. The 11 th Circuit Court in  C.F.T.C. v Sidoti                           
stated, “There must be a "relationship between the amount of disgorgement and the                         
amount of ill­gotten gain…” and “the disgorgement amount must be limited to the time                           
frame for which the party seeking disgorgement presented evidence of the defendant’s                       
bad acts.”,  C.F.T.C. v. Sidoti, 178 F.3d 1132, 1138 (11th Cir. 1999). In addition, the                           
Court’s power is not unlimited. In  S.E.C. v. ETS Payphones, Inc. the 11 th Circuit Court                             
stated that disgorgement can amount to a penalty if not applied correctly. “Therefore, a                         
court's power to order disgorgement is not unlimited. It extends only to the amount the                             
defendant profited from his wrongdoing…Any additional sum is impermissible as it                     
would constitute a penalty.”  S.E.C. v. ETS Payphones, Inc., 408 F.3d 727, 735 (11th Cir.                           
2005). 
Defendants argue that a different standard should be applied, and has been in                         
other FTC cases. The correct standard is damages and not disgorgement. See  Millsap v                           
McDonnell Douglas Corp ., 368 F.3d 1246 (10 th Cir. 2004), See also  Proudfoot Consulting                         
Co. v. Gordon , 576 F.3d 1223 (11 th Cir. 2009) This is not the only time this Circuit has                                   29
limited  the  disgorgement  requests  of  the  FTC.  Id . 
Contrary to what Plaintiff would like the Court believe, Defendants have actually                       
helped quite a few people and some of the people helped did pay full price for the                                 
Regimen. Defendants believe that the financial records will show that 1­5% of their                         
29  The  District  Court  in  this  case  granted  an  injunction  and  damages  instead  of  disgorgement. 
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customers have chosen to pay full price for the Regimen. In addition to this, Defendants                             
can accurately show there have been over 300 success stories from actual users of the                             
product.  In  Sharon  King’s  deposition  on  p.  149­150  she  stated  the  following  : 30
Q: In your experience, how representative was a story like                   
Sharon Hensley’s about the magnitude of weight loss. Was that                   
something that was unusually or something that you saw                 
frequently? 
 
A: No, I saw it frequently. I saw a lot of customers that                         
had  success.  Sarah,  Sarah  Durso  was  one.  
I mean the thing is I would see a lot that had success at                           
first, you know, were doing good. Same thing with Brian, I am                       
going to bring him up because Brian came and wrote a letter ­­                         
a thank you letter saying that, you know, this is the best thing                         
that has ever happened to him. You know, he didn’t think he                       
would  ever  lose  the  weight. 
I mean that’s how I found them from losing weight.                   
Same thing with Tarez (ph), you know, I found them from                     
reordering, I – you know, they lost weight, so, I would recruit                       




A: Yeah. I had one man that lost 200 pounds and went                       
skydiving. I mean A lot of people are so private about their                       
weight loss they don’t want people to know. He showed me this                       
video, said: Don’t tell anybody. I don’t want to be a coach. I                         
don’t want you to show my pictured to your boss or anything                       
its just between me and you Sharon. You know, I didn’t even                       
tell Don. You know, it was just like I had the communication                       
with  him,  so  you  know.  




Case 8:15-cv-02231-MSS-TBM   Document 167   Filed 05/09/17   Page 38 of 42 PageID 6726
A: It was more than a couple a month. I would say, you know,                           
maybe  about  20  a  month.  I  would  say  about  20  a  month.  
Based simply on the reorders alone, from the testimony of Sharon King,                       
Defendants state that hundreds of customers reordered the Regimen because it worked for                         
them. Comparatively, the FTC alleges that there have been “multiple” complaints against                       
Defendants. Defendants have had the opportunity to review the alleged “multiple                     
complaints” from the BBB. They have found that of the 33 BBB complaints, 2 were                             
related to advertising. All the rest were related to the physical effect that the Formula had                               
on  the  customer’s  body,  shipping,  or  customer  service.   31
Defendants state that the request of Plaintiff for disgorgement is over and beyond                         
what should be allowed in this action and hereby strenuously object. Even if the Court                             
did simple math and multiplied the actual complaints in relation to this action by 10 times                               
the  actual  harm,  it  would  not  even  come  close  to  what  the  FTC  is  requesting.   32
Plaintiff is attempting to downplay the actual good that the Defendant has done                         
for hundreds of people and punish them for the few disgruntled customers. (see PX# ­                             
Declarations of success stories). Defendants have stated that their intention was to help                         






33  https://asmbs.org/patients/bariatric­surgery­procedures#learnmore (May , 2017). See also “Cost of                 
Bariatric Surgery: 2014 Surgeon Survey & Key Findings”, J Quinlan, Bariatric Surgery Source, January                           
2015 and "Healthcare utilization and outcomes after bariatric surgery", Encinosa WE, Bernard DM, Chen                           
CC, Steiner CA Medical care  (2006). Approximately 50% of people who undergo bariatric surgery regain                             
the  weight  in  5  years.  
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questioned in deposition regarding the amount of effect Defendants have had in people’s                         
lives,  they  stated  the  following  : 34
Q:  No  wait.  Can  you  tell  me  what  Exhibit  144  consists  of? 





Q: You said you started Roca Labs essentially to help                   
people,  correct? 
A: I started because I want to make a difference in                     
people’s  live,  yeah.  




Defendants have also attempted to comply with the laws as they understood them.                         
Each time a state changed either their state law, or case law regarding the                           
non­disparagement clause, the Defendants changed their website to reflect this new                     
information.  
Defendants have also attempted to comply with the law regarding the advertising                       
each time they were informed. However, in this case the FTC has put the cart before the                                 
horse and failed to provide any warning letter or submission of any kind to Defendants. If                               
the FTC had provided a warning letter, as contemplated and now enforced through new                           
laws, the website would have changed and we would not be here today. Instead the FTC                               35
34  DX2,  606:25­607:13 
35 Consumer Review Fairness Act of 2016 requires that the FTC sends a warning letter to any companies                                   
who are not in compliance and has given a full year for compliance to take effect. The FTC is not able to                                           
prosecute  any  companies  until  2018.  
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chose to make an example of Defendants’ small company to look good in front of                             
Congress  in  order  to  get  a  new  law  on  the  books.   36
It is clear that Defendant have been drawn into a Federal Agency dispute and is                             
simply trying to avoid being smashed under the wheels of government bureaucracy.                       
Disgorgement is not the correct remedy for a company who simply got caught in the                             
middle of a Federal Agency tug­of­war involving a new and rapidly changing industry.                         




Defendants respectfully request this Court to DENY Plaintiffs’ Motion for                   
Summary Judgment and grant Defendants Motion for Partial Summary Judgment as to                       
Count Three of the Amended Complaint. Further, Defendants request that this Court                       













36 Consumer Review Fairness Act of 2016, H.R. 5111 – House Committee Notes (May 24, 2016. Testimony                                 
of Commissioner Edith Martinez before the 114 th House of Representatives Subcommittee on Commerce,                         
Manufacturing,  and  Trade). 
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The undersigned counsel certifies that on May 8, 2017, the foregoing was                       
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